4//SEC Filing
Satlin Andrew 4
Accession 0001209191-17-060943
CIK 0001567514other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:13 PM ET
Size
5.5 KB
Accession
0001209191-17-060943
Insider Transaction Report
Form 4
Satlin Andrew
EVP and Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2017-11-13+170,500→ 170,500 totalExercise: $14.79Exp: 2027-11-12→ Common Stock (170,500 underlying)
Footnotes (1)
- [F1]The option vests as to one third of the shares on November 13, 2018, one third of the shares on November 13, 2019 and one third of the shares on November 13, 2020.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001722858
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:13 PM ET
- Size
- 5.5 KB